IMUC
Vanguard Group’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-285,154
| Closed | -$60K | – | 4243 |
|
|
2018
Q3 | $60K | Hold |
285,154
| – | – | ﹤0.01% | 4112 |
|
|
2018
Q2 | $74K | Buy |
285,154
+205,588
| +258% | +$53.4K | ﹤0.01% | 4079 |
|
|
2018
Q1 | $20K | Buy |
+79,566
| New | +$20K | ﹤0.01% | 4089 |
|
|
2017
Q4 | – | Sell |
-62,760
| Closed | -$23K | – | 4161 |
|
|
2017
Q3 | $23K | Sell |
62,760
-617
| -1% | -$226 | ﹤0.01% | 4056 |
|
|
2017
Q2 | $55K | Buy |
63,377
+7,700
| +14% | +$6.68K | ﹤0.01% | 4022 |
|
|
2017
Q1 | $177K | Sell |
55,677
-5,034
| -8% | -$16K | ﹤0.01% | 3921 |
|
|
2016
Q4 | $125K | Sell |
60,711
-2,028,390
| -97% | -$4.18M | ﹤0.01% | 3957 |
|
|
2016
Q3 | $246K | Sell |
2,089,101
-469,773
| -18% | -$55.3K | ﹤0.01% | 3870 |
|
|
2016
Q2 | $589K | Hold |
2,558,874
| – | – | ﹤0.01% | 3754 |
|
|
2016
Q1 | $742K | Sell |
2,558,874
-13,500
| -0.5% | -$3.92K | ﹤0.01% | 3681 |
|
|
2015
Q4 | $914K | Buy |
2,572,374
+10,700
| +0.4% | +$3.8K | ﹤0.01% | 3655 |
|
|
2015
Q3 | $1.08M | Buy |
2,561,674
+27,454
| +1% | +$11.5K | ﹤0.01% | 3609 |
|
|
2015
Q2 | $1.2M | Buy |
2,534,220
+107,963
| +4% | +$51K | ﹤0.01% | 3613 |
|
|
2015
Q1 | $1.18M | Buy |
2,426,257
+677,600
| +39% | +$329K | ﹤0.01% | 3589 |
|
|
2014
Q4 | $1.28M | Buy |
1,748,657
+57,214
| +3% | +$41.8K | ﹤0.01% | 3445 |
|
|
2014
Q3 | $1.51M | Buy |
1,691,443
+39,600
| +2% | +$35.2K | ﹤0.01% | 3374 |
|
|
2014
Q2 | $1.85M | Hold |
1,651,843
| – | – | ﹤0.01% | 3288 |
|
|
2014
Q1 | $2.02M | Buy |
1,651,843
+183,775
| +13% | +$224K | ﹤0.01% | 3220 |
|
|
2013
Q4 | $1.36M | Buy |
1,468,068
+107,130
| +8% | +$99.1K | ﹤0.01% | 3329 |
|
|
2013
Q3 | $3.5M | Buy |
1,360,938
+304,000
| +29% | +$781K | ﹤0.01% | 2918 |
|
|
2013
Q2 | $2.05M | Buy |
+1,056,938
| New | +$2.05M | ﹤0.01% | 3057 |
|